EchoStar Corporation Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? EchoStar Corporation Common Stock trades at $97.64 (market cap $27.15B), while Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B). The key difference: EchoStar Corporation Common Stock is far larger — about 7.1× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, EchoStar Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EchoStar Corporation Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| ECHO | RLAY | |
|---|---|---|
Market Cap | $27.15B | $3.82B |
Volume | 4,944,235 | 4,332,079 |
Sector | Media | Health |
52-Week High | $141.80 | $20.75 |
52-Week Low | $66.93 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $44.21B | $2.93B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EchoStar provides satellite communications and connectivity services. Its businesses support broadband, enterprise, government, and consumer communications needs.
Read more on ECHO →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →